140 related articles for article (PubMed ID: 2505604)
1. Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.
Tebbe U; Tanswell P; Seifried E; Feuerer W; Scholz KH; Herrmann KS
Am J Cardiol; 1989 Sep; 64(8):448-53. PubMed ID: 2505604
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
Hackett D; Andreotti F; Haider AW; Brunelli C; Shahi M; Fussell A; Buller N; Foale R; Lipkin D; Caponnetto S
Am J Cardiol; 1992 Jun; 69(17):1393-8. PubMed ID: 1590225
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarction.
Khan MI; Hackett DR; Andreotti F; Davies GJ; Regan T; Haider AW; McFadden E; Halson P; Maseri A
Am J Cardiol; 1990 May; 65(16):1051-6. PubMed ID: 2109926
[TBL] [Abstract][Full Text] [Related]
4. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
[TBL] [Abstract][Full Text] [Related]
5. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.
Kalbfleisch J; Thadani U; LittleJohn JK; Brown G; Magorien R; Kutcher M; Taylor G; Maddox WT; Campbell WB; Perry J
Am J Cardiol; 1992 May; 69(14):1120-7. PubMed ID: 1575179
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
8. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
Neuhaus KL; von Essen R; Vogt A; Tebbe U; Rustige J; Wagner HJ; Appel KF; Stienen U; König R; Meyer-Sabellek W
J Am Coll Cardiol; 1994 Jul; 24(1):55-60. PubMed ID: 8006283
[TBL] [Abstract][Full Text] [Related]
9. Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction.
Tebbe U; von Essen R; Smolarz A; Limbourg P; Rox J; Rustige J; Vogt A; Wagner J; Meyer-Sabellek W; Neuhaus KL
Am J Cardiol; 1993 Sep; 72(7):518-24. PubMed ID: 8362764
[TBL] [Abstract][Full Text] [Related]
10. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
Longridge DJ; Follenfant MJ; Ford AJ
Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
[TBL] [Abstract][Full Text] [Related]
11. Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
Johns JA; Gold HK; Leinbach RC; Yasuda T; Gimple LW; Werner W; Finkelstein D; Newell J; Ziskind AA; Collen D
Circulation; 1988 Sep; 78(3):546-56. PubMed ID: 3136953
[TBL] [Abstract][Full Text] [Related]
12. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.
Neuhaus KL; Feuerer W; Jeep-Tebbe S; Niederer W; Vogt A; Tebbe U
J Am Coll Cardiol; 1989 Nov; 14(6):1566-9. PubMed ID: 2509531
[TBL] [Abstract][Full Text] [Related]
13. Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
J Am Coll Cardiol; 1988 Sep; 12(3):581-7. PubMed ID: 3042835
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration.
McKendall GR; Attubato MJ; Drew TM; Feit F; Sharaf BL; Thomas ES; Teichman S; McDonald MJ; Williams DO
J Am Coll Cardiol; 1991 Dec; 18(7):1774-8. PubMed ID: 1960329
[TBL] [Abstract][Full Text] [Related]
15. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
Gao R
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
[TBL] [Abstract][Full Text] [Related]
17. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Grines CL; Nissen SE; Booth DC; Branco MC; Gurley JC; Bennett KA; DeMaria AN
J Am Coll Cardiol; 1989 Sep; 14(3):573-80. PubMed ID: 2504797
[TBL] [Abstract][Full Text] [Related]
18. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a two-hour infusion of 150-mg tissue plasminogen activator in acute myocardial infarction.
Lew AS; Cercek B; Lewis BS; Hod H; Shah PK; Ganz W
Am J Cardiol; 1987 Dec; 60(16):1225-9. PubMed ID: 3120567
[TBL] [Abstract][Full Text] [Related]
20. Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimens.
Smalling RW; Schumacher R; Morris D; Harder K; Fuentes F; Valentine RP; Battey LL; Merhige M; Pitts DE; Lieberman HA
J Am Coll Cardiol; 1990 Apr; 15(5):915-21. PubMed ID: 2107237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
